Telmisartan in high-risk patients intolerant of ACE inhibitors

Lancet. 2009 Feb 7;373(9662):457-8; author reply 459. doi: 10.1016/S0140-6736(09)60161-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Benzoates / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Reproducibility of Results
  • Research Design*
  • Telmisartan

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzimidazoles
  • Benzoates
  • Telmisartan